The precise insertion of DNA sequences using the homology-directed repair (HDR) pathway is one potential use of the CRISPR/Cas genome editing technology. Various circumstances could influence the ...
Investing.com - Homology Medicines (NASDAQ: FIXX) reported first quarter EPS of $-0.600, $0.11 worse than the analyst estimate of $-0.492. Revenue for the quarter ...
Some results have been hidden because they may be inaccessible to you